BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.81 USD | -0.49% |
|
-1.93% | -22.40% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Discovering, Developing and Delivering Worldwide Innovative Therapies | 14.38B | 13.44B | 10.98B | 10.17B | 9.84B | |||||
Total Assets | 27.23B | 24.62B | 23.88B | 24.55B | 26.84B | |||||
Interest Expense | -187M | -213M | -254M | -247M | -247M | |||||
Income Tax Expense | 1.16B | 992M | 52.5M | 633M | 135M | |||||
CAPEX | -514M | -425M | -258M | -243M | -277M | |||||
EBT | 7.13B | 5.05B | 1.75B | 3.59B | 1.3B | |||||
D&A | 465M | 457M | 488M | 518M | 495M | |||||
Operating Income | 7.04B | 4.55B | 2.84B | - | - | |||||
Net Income | 5.89B | 4B | 1.56B | 3.05B | 1.16B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 9.51B | 8.53B | 5.83B | 5.53B | 5.43B | |||||
Total Assets | 1.49B | 1.5B | 1.39B | 1.37B | 1.44B | |||||
Europe | - | - | 2.64B | 2.41B | 2.14B | |||||
Total Assets | - | - | 2.34B | 2.28B | 2.25B | |||||
Germany | - | - | 1.16B | 926M | 868M | |||||
Total Assets | - | - | 25.4M | 21M | 17.5M | |||||
Asia | 432M | 630M | 725M | 720M | 863M | |||||
Total Assets | 6.2M | 16.2M | 16.4M | 13.7M | 8.3M | |||||
Other | 630M | 619M | 627M | 583M | 531M | |||||
Total Assets | 12M | 10.9M | 21.7M | 22.6M | 12.9M | |||||
Europe (Incl. Germany) | 3.8B | 3.66B | - | - | - | |||||
Total Assets | 2.16B | 2.32B | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 2.03B | 2.18B | - | - | - |
- Stock Market
- Equities
- BIIB Stock
- Financials Biogen Inc.
- Business Segments